| ¿µ¹® | drug dependence | ÇÑ±Û | ¾à¹°ÀÇÁ¸(¼º) |
|---|---|---|---|
| ¼³¸í | ¾î¶² Á¾·ùÀÇ ¾à¹°À» ¹Ýº¹Çؼ »ç¿ëÇÏ´Â µ¿¾È ±× ¾àÀÇ »ç¿ëÀ» ÁßÁöÇÒ ¼ö ¾ø°Ô µÇ´Â »óÅÂ. ÀÇÁ¸ÀÇ Á¤µµ°¡ ½ÉÇØÁö¸é ¾à ¾øÀÌ´Â »ýȰÇÒ ¼ö ¾ø´Â »óÅ¿¡ ºüÁö°í, ±× °á°ú ¹ýÀ» ¾î±â¸é¼±îÁö ¾àÀ» ±¸ÀÔÇÏ°Ô µÈ´Ù. ÀÌÀü¿¡´Â ¾à¹°¸¸¼ºÁßµ¶, ¾à¹°³²¿ë, ¾à¹°½À°ü¼ºÀ̶ó´Â °³³äÀ¸·Î ³ª´©¾îÁ® ÀÖ¾úÁö¸¸, WHO¿¡¼´Â À̰͵éÀ» ¸ðµÎ Æ÷ÇÔ½ÃÄѼ ¾à¹°ÀÇÁ¸À̶ó ÇÏ¿´´Ù. »óÅ¿¡ ÀÇÇÑ ºÐ·ù¶ó ¾à¹°ÀÛ¿ë¿¡ ÀÇÇÑ ºÐ·ù°¡ ÀÖ´Ù. »óÅ¿¡ ÀÇÇÑ °ÍÀº 1.Á¤½ÅÀû ÀÇÁ¸: ¾à¹°ÀÇ »ç¿ëÀ» ÁßÁöÇÏ¸é ºÒ¾È°¨-¿ì¿ï°¨-ÃÊÁ¶°¨ µîÀÇ ½É¸®ÀûÀÎ Áõ»óÀÌ ³ªÅ¸³ª ´Ù½Ã ¾à¹°À» ã°Ô µÇ´Â °æ¿ì. ¾àÀ» ²÷¾úÀ» °æ¿ì¿¡ ³ªÅ¸³ª´Â ½ÅüÁõ»óÀÎ ±Ý´ÜÁõ»óÀº ³ªÅ¸³ªÁö ¾ÊÀ¸¸ç, ¾à¹°ÀÇ Áö¼ÓÀû º¹¿ë¿¡ ÀÇÇØ¼ Á¡Â÷ ¾à¹°¿¡ ´ëÇÑ ½ÅüÀÇ ¹ÝÀÀÀÌ ÁÙ¾îµå´Â Çö»óÀÎ ¾à¹°ÀÇ ³»¼ºµµ ³ªÅ¸³ªÁö ¾Ê´Â´Ù. 2.½ÅüÀû ÀÇÁ¸: ¾à¹° »ç¿ëÀ» ÁßÁöÇÏ¸é ½ÅüÀûÀÎ Àå¾Ö, Áï ±Ý´ÜÁõ»óÀ» ÀÏÀ¸Å°°í ±× °íÅëÀ» ´Þ·¡±â À§ÇØ ¾à¹°À» ã°Ô µÇ´Â °æ¿ìÀÌ´Ù. ´ëºÎºÐ ³»¼ºÀÌ ³ªÅ¸³ª´Âµ¥ °³º°ÀûÀ¸·Î ³ªÅ¸³ª´Â °æ¿ìµµ ÀÖÁö¸¸ ÁÖ·Î º´ÇàÇØ¼ ³ªÅ¸³´Ù. |
||
| ¿µ¹® | dependence | ÇÑ±Û | ÀÇÁ¸¼º |
|---|---|---|---|
| ¼³¸í | Àΰ£°ú Àΰ£ »çÀÌÀÇ Çൿ¿¡¼ º¼ ¼ö ÀÖ´Â ÇϳªÀÇ Çü½ÄÀ̸ç, ŸÀΰúÀÇ Á¢ÃË È¤Àº ŸÀÎÀ¸·ÎºÎÅÍÀÇ º¸È£¿¡ ÀÇÇØ »ý±â´Â ¸¸Á·À» ÁöÇâÇÏ´Â Çൿ. ÀÇÁ¸Àû Çൿ¿¡´Â ´ÙÀ½°ú °°Àº °ÍµéÀÌ ÀÖ´Ù. 1) °°ÀÌ Àֱ⸦ ¹Ù¶õ´Ù. 2) ÁÖÀǸ¦ ±â¿ï¿© Áֱ⸦ ¹Ù¶õ´Ù. 3) Á¶·ÂÀ» ±¸ÇÑ´Ù. 4) º¸ÁõÀ» ¹Ù¶õ´Ù. 5) ¸¶À½ÀÇ ÁöÁÖ°¡ µÇ±â¸¦ ¹Ù¶õ´Ù. Á¾·¡¿¡´Â ÀÇÁ¸Àû ÇൿÀº ¿µÀ¯¾Æ¿¡°Ô ¸¹¾Ò°í ¿¬·ÉÀÌ ¸¹¾ÆÁü¿¡ µû¶ó °¨¼ÒÇÏ¿© ÀÚ¸³ÇØ ³ª°£´Ù°í »ý°¢Çß¾úÁö¸¸, ÃÖ±Ù ÀÇÁ¸À̶õ »ç¶÷¿¡°Ô º¸ÆíÀûÀÎ °ÍÀ̸ç, ¹ß´Þ°ú ´õºÒ¾î º¸´Ù ´Ù¾çÇÏ°í °íÂ÷ÀûÀ¸·Î ±¸Á¶ÈÇÑ °ÍÀ¸·Î º¯ÈµÈ´Ù´Â °ßÇØ°¡ ¸¹¾ÆÁö°í ÀÖ´Ù. ¶Ç ¸¶¾à°ú °°Àº ¾à¹°À» ²÷À» ¼ö ¾ø´Â °æ¿ìÀÇ ¾à¹°ÀÇÁ¸ µî¿¡µµ »ç¿ëÇÑ´Ù. |
||
| narco | narcotic, narcotic addict, drug enforcement agent |
|---|---|
| NA | 1) Narcotic Anonymous 2) Nomina Anatomica; Anatomic Nomenclature; ÇØºÎÇÐ ¸í¸í¹ý... |
| NARC | narcotic; National Association for Retarded Children; nucleus arcuatus |
| NDSB | Narcotic Drugs Supervisory Board |
| NNAS | neonatal narcotic abstinence syndrome |
| ADS | Alcohol Dependence Scale |
|---|---|
| FTND | Fagerstrom Test for Nicotine Dependence |
| RD | Reward Dependence |
| SADQ | Severity of Alcohol Dependence Questionnaire |
| AD | alcohol dependence |
| analgesics, non-narcotic | Drugs that have principally analgesic, antipyretic, and anti-inflammatory actions. They do not bind to opioid receptors and are not classified under the controlled substances act. (12 Dec 1998) |
|---|---|
| narcotic | 1. Pertaining to or producing narcosis. 2. <pharmacology> An agent that produces insensibility or stupor, applied especially to the opioids, i.e. To any natural or synthetic drug that has morphine like actions. Origin: Gr. Narkotikos = benumbing, deadening (18 Nov 1997) |
| narcotic analgesic agent | <pharmacology> Medications that relieve pain but have addictive potential if used regularly. Examples include: meperidine, morphine, propoxyphene, codeine, hydrocodone, oxycodone, hydromorphone, nalbuphine, butorphanol and heroin. (27 Sep 1997) |
| narcotic analgesics | <pharmacology> Medications that relieve pain but have addictive potential if used regularly. Examples include: meperidine, morphine, propoxyphene, codeine, hydrocodone, oxycodone, hydromorphone, nalbuphine, butorphanol and heroin. (27 Sep 1997) |
| narcotic antagonists | Agents inhibiting the effect of narcotics on the central nervous system. (12 Dec 1998) |
| narcotic blockade | The use of drugs to inhibit the effects of narcotic substances, as with naloxone. (05 Mar 2000) |
| narcotic hunger | The physiological craving for narcotics. (05 Mar 2000) |
| narcotic reversal | The use of narcotic antagonists, such as naloxone, to terminate the action of narcotics. (05 Mar 2000) |
| drug and narcotic control | Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval (drug approval), and marketing of drugs. (12 Dec 1998) |
| anchorage dependence | <cell biology, cell culture> The necessity for attachment (and spreading) in order that a cell will grow and divide in culture. Loss of anchorage dependence seems to be associated with greater independence from external growth control and is probably one of the best correlates of tumourigenicity in vivo. Anchorage independence is usually detected by cloning cells in soft agarose, only anchorage independent cells will grow and divide (as they will in suspension). (18 Nov 1997) |
| physical dependence | <pharmacology> Physiologic adaptation of the body to the presence of opioid is required to maintain the same level of analgesia. (31 Dec 1997) |
| morphine dependence | Strong dependence, both physiological and emotional, upon morphine. (12 Dec 1998) |
| heroin dependence | Strong dependence, both physiological and emotional, upon heroin. (12 Dec 1998) |
| psychological dependence | <psychiatry> Pattern of compulsive drug use characterised by a continued craving for an opioid and the need to use the opioid for effects other than pain relief. (16 Dec 1997) |
| substance dependence | A pattern of behavioural, physiologic, and cognitive symptoms that develop due to substance use or abuse; usually indicated by tolerance to the effects of the substance and withdrawal symptoms that develop when use of the substance is terminated. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|